Following the inquiry in the clinical establishment, the final prescription articles is transmitted within the health-related establishment into the information method if the prescription drug is decided. When an insurance policy pharmacy inquires about The supply of insurance plan for prescription drugs explained in prescriptions, the existence / absence of the inquiry background Using the medical establishment and the outcomes are distributed. Last but not least, a series of inquiry histories is distributed on the evaluation and payment institution and the insurer, and also the information inquiry / judgment process is finished.
During the pharmaceutical prescription information inquiry / distribution program according to claim 1, if the results of resolve is that the inquiry articles would not conform to the input information and selected conditions from the examination and payment institution as well as the insurance company, lookup and recognize the pharmaceutical group that satisfies these Pharmaceutical prescription information inquiry / distribution program characterized by distribution to clinical establishments.
Authorized status (The lawful status is an assumption and isn't a lawful summary. Google hasn't executed a lawful Evaluation and tends to make no illustration as on the precision on the standing outlined.)
請求項１に記載の医薬品処方情報照会・配信システムにおいて、個々の診療行為毎に医療機関から医薬品処方につき照会を受付け、照会時に医療機関から提示される被保険者情報（医療保険関連情報、傷病・症状等の情報等）と、予め取得した情報とを照合し、被保険者が加入している保険者並びに担当の審査支払機関の指定条件を満たしているか否かをリアルタイムで判定することを特徴とする医薬品処方情報照会・配信システム。
The present creation relates to transactions related to prescription and buy of ethical drugs involving suppliers and prescribers for example healthcare establishments and insurance policy pharmacies and people including assessment payers, insurers and insured individuals from the pharmaceutical distribution industry. It results in being achievable to explain whether or not There exists settlement in between the functions in authentic time. Because of this, the assessment / payment establishment / insurance company will have an opportunity to effectively Specific their intentions regarding the choice of drugs, which allows them to broaden their choices for drug prescriptions they need and make improvements to their satisfaction and cost usefulness.
医療機関による医薬品の処方に際しては、被保険者（患者）が保健医療機関で医師の診察を受け、その診断結果をもとに医師が処方箋を発行、同処方箋に基づき保険薬局にて医薬品が調剤、提供される、という流れになっている。保険が適用される医薬品の費用請求については、被保険者による一部費用負担を除くと、医療機関・保険薬局などが、レセプトと呼ばれる診療報酬明細書に、診療、検査、投薬、手術など医療行為の内容を記入し、月ごとに審査支払機関に提出、医療費を請求する。審査は、社会保険診療報酬支払基金と都道府県支部、国民健康保険中央会と各都道府県の国民健康保険団体連合会にて実施され、かかった医療費をそのまま医療保険から支払う「出来高払い制」を採用されている。
従って、本発明の課題は、わが国の医療保険制度の中で、医療サービス受給の公平性を維持しつつ、被保険者・保険者もしくは審査支払機関が、代替品の中から最も強く処方を希望する医薬品を、医療機関・保険薬局が、他の代替品の中から優先的に採用する機会を提供することを可能にさせる、医療用医薬品処方情報照会・配信システムを提供することにある。
【解決手段】保険医療機関が処方する医薬品について、代替品情報、保険者の処方希望優先順位情報を入力・保持する手段、審査支払機関によるレセプト審査承認のための条件・基準を入力・保持する手段、医療機関から診療行為毎に、処方医薬品の保険適用可否に関する照会を受付け、被保険者の症状等の個人情報に基づき、照会内容が保険者・審査支払機関の指定条件に合致しているか否かを判定する手段、上記照会内容が指定条件に合致していない場合は、保険者が指定する医薬品の中から、症状等の被保険者の情報に基づき指定条件を満たす他の医薬品を検索し代替品として医療機関に通知、医療機関にて処方内容の再選択を促す手段を有するシステム。
It can be an item of the present invention to provide a prescription information inquiry / distribution program for prescription information that permits clinical establishments / coverage pharmacies to preferentially undertake the choice medicines from other solutions. 前記課題を解決するための本発明は、以下の各部から構成されることを特徴とする
Choose a default timezone, and permit very well remaining knowledge syncs and placement details. This past part is very important for somebody hoping to handle indications connected to their neighborhood weather and pollen.
Also, the evaluation and payment establishment plus the insurance company will specify the medicines that they want to preferentially prescribe. The designation system is as follows: (1) Specify the title of a specific team of drugs for each personal injury and symptom categorized Based on many problems including the insured's age, gender, constitution and medical heritage. Or use (two) the upper Restrict on the medical website remuneration score / applied drug insurance policy rating and permit the prescription with the drug given that the higher limit is not exceeded. These input information and specified problems are saved as data inside the information process.
Consider therapy modification - facts show that the required agents may perhaps communicate with one another within a clinically-important method and patient-certain evaluation has to be performed to find out regardless of whether the main advantages of concomitant therapy outweigh the challenges. Distinct steps needs to be taken in order to realize the benefits and/or limit toxicity of concomitant use. Stay clear of blend - knowledge display that the required brokers may perhaps communicate with each other inside a clinically-sizeable way and the risk frequently outweighs any potential profit. Concurrent use of such agents is generally considered contraindicated. Exam Interactions - Listing of assay interferences when pertinent
・ Information for instance symptom and so on.) and information acquired upfront are checked to ascertain in real time whether or not the insured that is insured and also the specified examination and payment Business in demand are glad. Pharmaceutical prescription information inquiry / distribution system.
Each time a prescription encouraged drugs is selected by a health care establishment, the handling status / inventory status at a nearby insurance pharmacy is confirmed and the result is notified.